X
Get new exclusive access to healthcare business reports & breaking news
Pharma
A new Alzheimer’s treatment could cost Medicare billions of dollars by next year — well over Wall Street ...
Astellas Pharma Inc. and Kelonia Therapeutics announced February 15th that Xyphos Biosciences, Inc., (a wholly owned subsidiary of ...
AbbVie announced February 20th Robert A. Michael, AbbVie’s current president and chief operating officer, has been unanimously selected ...
Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company, announced January 23rd positive initial clinical results ...
EraCal Therapeutics Ltd. announced January 23rd it has entered into a collaboration and license agreement with Novo Nordisk ...
Sanofi and Inhibrx, Inc. (“Inhibrx”), a publicly traded clinical-stage biopharmaceutical company focused on developing a broad pipeline of ...
Drug characterization and release testing constitute pivotal stages in the pharmaceutical development process. Through the utilization of comprehensive ...
United Therapeutics Corporation and Miromatrix Medical Inc. announced October 30th a definitive agreement for United Therapeutics to acquire ...
Late October, Sanofi provided a comprehensive update regarding its Play to Win strategy, continuing to focus on executing ...
